“Whoa! It’s like Spotify but for academic articles.”

Instant Access to Thousands of Journals for just $40/month

Development of Homogeneous High-Affinity Agonist Binding Assays for 5-HT 2 Receptor Subtypes

The serotonin (5-hydroxytryptamine) 5-HT 2 receptor subfamily consists of three members, 5-HT 2A , 5-HT 2B , and 5-HT 2 C. These receptors share high homology in their amino acid sequence, have similar signaling pathways, and have been indicated to play important roles in feeding, anxiety, aggression, sexual behavior, mood, and pain. Subtype-selective agonists and antagonists have been explored as drugs for hypertension, Parkinson's disease, sleep disorders, anxiety, depression, schizophrenia, and obesity. In this study, we report the development of homogeneous agonist binding assays in a scintillation proximity assay (SPA) format to determine the high-affinity binding state of agonist compounds for the human 5-HT 2C , 5-HT 2A , and 5-HT 2B receptors. The 5-HT 2 agonist 1-(4- 125 Iiodo-2,5-dimethoxyphenyl)-2-aminopropane ( 125 IDOI) was used to label the high-affinity sites for the 5-HT 2A and 5-HT 2C receptors. The high-affinity sites for the 5-HT 2B receptor were labeled with 3 Hlysergic acid diethylamide. Total receptor expression was determined with the 5-HT 2 antagonist 3 Hmesulergine for the 5-HT 2B and 5-HT 2C receptors, and 3 Hketanserin for the 5-HT 2A receptor. The agonist high-affinity binding sites accounted for 2.3% (5-HT 2C receptor), 4.0% (5-HT 2A receptor), and 22% (5-HT 2B receptor) of the total receptor population. Competition binding studies using known agonists indicated high Z′ values of the agonist binding assays in SPA format ( Z ′ > 0.70). The K i values of 5-HT, ( R )(-)DOI, and VER-3323 for the 5-HT 2A , 5-HT 2B , and 5-HT 2C receptors by SPA format were equivalent to published data determined by filtration binding assays. These results indicate that agonist binding assays in SPA format can be easily adapted to a highthroughput assay to screen for selective 5-HT 2C receptor agonists, as well as for selectivity profiling of the compounds. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png ASSAY and Drug Development Technologies Mary Ann Liebert

Development of Homogeneous High-Affinity Agonist Binding Assays for 5-HT 2 Receptor Subtypes

Abstract

The serotonin (5-hydroxytryptamine) 5-HT 2 receptor subfamily consists of three members, 5-HT 2A , 5-HT 2B , and 5-HT 2 C. These receptors share high homology in their amino acid sequence, have similar signaling pathways, and have been indicated to play important roles in feeding, anxiety, aggression, sexual behavior, mood, and pain. Subtype-selective agonists and antagonists have been explored as drugs for hypertension, Parkinson's disease, sleep disorders, anxiety, depression, schizophrenia, and obesity. In this study, we report the development of homogeneous agonist binding assays in a scintillation proximity assay (SPA) format to determine the high-affinity binding state of agonist compounds for the human 5-HT 2C , 5-HT 2A , and 5-HT 2B receptors. The 5-HT 2 agonist 1-(4- 125 Iiodo-2,5-dimethoxyphenyl)-2-aminopropane ( 125 IDOI) was used to label the high-affinity sites for the 5-HT 2A and 5-HT 2C receptors. The high-affinity sites for the 5-HT 2B receptor were labeled with 3 Hlysergic acid diethylamide. Total receptor expression was determined with the 5-HT 2 antagonist 3 Hmesulergine for the 5-HT 2B and 5-HT 2C receptors, and 3 Hketanserin for the 5-HT 2A receptor. The agonist high-affinity binding sites accounted for 2.3% (5-HT 2C receptor), 4.0% (5-HT 2A receptor), and 22% (5-HT 2B receptor) of the total receptor population. Competition binding studies using known agonists indicated high Z′ values of the agonist binding assays in SPA format ( Z ′ > 0.70). The K i values of 5-HT, ( R )(-)DOI, and VER-3323 for the 5-HT 2A , 5-HT 2B , and 5-HT 2C receptors by SPA format were equivalent to published data determined by filtration binding assays. These results indicate that agonist binding assays in SPA format can be easily adapted to a highthroughput assay to screen for selective 5-HT 2C receptor agonists, as well as for selectivity profiling of the compounds.
Loading next page...
 
/lp/mary-ann-liebert/development-of-homogeneous-high-affinity-agonist-binding-assays-for-5-QL4r87KPVe

Sorry, we don’t have permission to share this article on DeepDyve,
but here are related articles that you can start reading right now:

Explore the DeepDyve Library

How DeepDyve Works

Spend time researching, not time worrying you’re buying articles that might not be useful.

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from Springer, Elsevier, Nature, IEEE, Wiley-Blackwell and more.

All the latest content is available, no embargo periods.

See the journals in your area

Simple and Affordable Pricing

14-day free trial. Cancel anytime, with a 30-day money-back guarantee.

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$40/month

Best Deal — 25% off

Annual Plan

  • All the features of the Professional Plan, but for 25% off!
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$30/month
billed annually